ReviewInflammopharmacology2026
A comprehensive review of the phytochemical, and pharmacological potential of Alnus hirsuta (Spach) Rupr., (Siberian Alder): implications for anti-inflammatory therapeutics.
Review in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alnus hirsuta (Siberian alder), a member of the family Betulaceae, is a medicinally significant species that has yet to be the subject of a comprehensive review. This article summarizes phytochemical constituents, and pharmacological activities of A. hirsuta. Phytochemical studies have identified a diverse range of secondary metabolites, including diarylheptanoids, terpenoids, flavonoids, and phenolic compounds, many of which exhibit strong bioactivities. Pharmacological investigations have revealed anti-inflammatory, anticancer, antioxidant, anti-melanogenesis, hepatoprotective, lipid-regulating, and hair growth effects with diarylheptanoids frequently implicated as major bioactive constituents. Mechanistically, these compounds especially diarylheptanoids modulate inflammation by inhibiting NF-κB and MAPK pathways, suppressing pro-inflammatory mediators such as COX-2, iNOS, and cytokines, while simultaneously enhancing antioxidant defenses. Thus, by integrating chemical and biological evidence, to our knowledge, this review presents the first comprehensive account of A. hirsuta, emphasizing the potential of this species as a valuable source of natural products for drug discovery.
Indexed as
Identifiers
41954873What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.